Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
Status:
Completed
Trial end date:
2019-08-12
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, open-label, blinded end-point evaluation trial. The
patient population consists of patients on hemodialysis who have atrial fibrillation (AF) and
end-stage renal disease (ESRD) .